Beauty procedure. Woman receiving hyaluronic acid injection in spa salon
Bioresorbable Powders for Medical Aesthetics

Bioresorbable biomaterials for next-generation dermal fillers and biostimulators

Evonik supports dermal filler manufacturers with high‑purity biomaterials designed to meet evolving requirements for patient safety, clinical performance, and regulatory compliance. The global medical aesthetics market continues to evolve beyond traditional volumizing approaches toward products designed to support skin quality, collagen formation and long-term aesthetic outcomes.

Our bioresorbable powders enable next‑generation dermal filler formulations that go beyond volume replacement to support aesthetic injectable treatments, including biostimulators, skin boosters, and regenerative approaches.

With decades of experience in medical polymers and regulated manufacturing, Evonik partners with customers from early material selection through clinical and commercial readiness. 

Bioresorbable biomaterials for next-generation dermal fillers and biostimulators

Evonik supports dermal filler manufacturers with high‑purity biomaterials designed to meet evolving requirements for patient safety, clinical performance, and regulatory compliance. The global medical aesthetics market continues to evolve beyond traditional volumizing approaches toward products designed to support skin quality, collagen formation and long-term aesthetic outcomes.

Our bioresorbable powders enable next‑generation dermal filler formulations that go beyond volume replacement to support aesthetic injectable treatments, including biostimulators, skin boosters, and regenerative approaches.

With decades of experience in medical polymers and regulated manufacturing, Evonik partners with customers from early material selection through clinical and commercial readiness. 

Advancing Aesthetic Injectable Technologies with Next Generation Bioresorbable Biomaterials

The medical aesthetics market continues to evolve toward products designed to support the body's natural regenerative processes. Today’s aesthetic biomaterials are expected to improve skin quality and deliver predictable, natural-looking results.

Evonik’s bioresorbable powders are ideally suited for next‑generation injectables in medical aesthetics, offering:

  • High biocompatibility and safety profile
  • Tunable degradation behavior
  • Proven regulatory pathway

RESOMER® bioresorbable polymer powders

Evonik’s RESOMER® portfolio includes highly pure bioresorbable polymers such as Poly‑L‑lactic acid (PLLA), Polycaprolactone (PCL), and Polydioxanone (PDO) and multiple copolymers.

Available as ultra-fine powders and microgranules, these materials are well suited for aesthetic injectable applications. Their consistent quality and controlled physical characteristics support formulation development across a broad range of medical aesthetic products.

RESOMER®: differentiation through customization

A key part of Evonik’s offering for medical aesthetics is the RESOMER® Powder Platform. This includes two standard RESOMER® powder grades, and RESOMER® Powder Select, which can be tailored to specific application requirements.

Our proprietary solvent‑free RESOMER® micronization technology allows production of high‑purity bioresorbable powders without solvent residues.

Key advantages include:

  • ISO 13485 and GMP manufacturing
  • Clean‑room processing (ISO Class 8)
  • Configurable particle characteristics to support formulation requirements
  • Scalable production from lab to commercial volumes

The RESOMER® Powder Platform can be utilized for dermal filler applications, enabling control over material characteristics that support formulation development and product differentiation. This platform supports manufacturers to differentiate formulations while reducing development risk and accelerating time‑to‑market.

Biomaterials for advanced aesthetic injectable formulations

Whether developing a biostimulator, a skin booster, or other medical devices for aesthetic applications, Evonik’s biomaterials offer flexibility in degradation behavior, mechanical properties, and biological performance.

In addition to RESOMER®, Evonik offers VECOLLAN®, a recombinant collagen platform designed to provide the benefits of a highly consistent, non-animal-derived biomaterial. Produced through advanced biotechnology, VECOLLAN® combines purity, scalability and design flexibility, creating opportunities for differentiated medical aesthetic products. As interest in biomimetic and regenerative approaches continues to grow, VECOLLAN® provides developers with an innovative platform for exploring next-generation aesthetic applications.

Why partner with Evonik for medical aesthetic applications?

  • Broad portfolio of bioresorbable and biocompatible materials
  • Unique RESOMER® Powder Platform with customization capability
  • Strong application, formulation, and regulatory support
  • GMP and ISO 13485 manufacturing
  • Decades of experience supporting global medical device manufacturers

Evonik's portfolio of biomaterials for dermal fillers

RESOMER®

... is a biodegradable polymer that is widely used in the medical technology industry. It is known for its excellent biocompatibility, controlled degradation, and tunable properties, making it an ideal material for medical applications.

VECOLLAN®

...is a recombinant, non-animal-derived collagen-like biomaterial designed for next-generation medical devices. Now available in a clinical-grade, Vecollan® is a sustainable fermentation-based, animal-free collagen alternative, offering high purity and tunable properties.


Frequently asked questions (FAQ)

Evonik supplies high‑purity bioresorbable polymer powders and microgranules used by medical device manufacturers in the development of aesthetic injectable products. RESOMER® materials are supplied as raw materials and are not finished medical devices. Product formulation, regulatory approval, and commercialization remain the responsibility of the medical device manufacturer.

RESOMER® powders are incorporated into dermal filler formulations, where they are suspended or processed into injectable systems. After formulation into finished injectable products, bioresorbable polymers may contribute to application-specific performance characteristics depending on product design and intended clinical use.

Material characteristics, including particle size, can influence product performance attributes such as handling, degradation behavior, and biological interaction. Evonik's customizable powder platform allows manufacturers to tailor materials to specific development objectives.

Bioresorbable polymers are designed to degrade safely in the body over time. Their degradation profile and material properties make them suitable for a wide range of aesthetic injectable applications, depending on the intended product design.


ANY QUESTIONS? JUST CONTACT US.

"Our global team of experts is ready to support you with all questions around our product and service portfolio for aesthetic dermatology. Contact us to profit from more than 30 years of application know-how in the field of medical devices and find your individual solution!"

 

Mandy Roovers-Wiermans
Business Development Manager Medical Device Solutions

Send me a message
Alternative image

More about our offerings for medical devices

SONY DSC

Aesthetic Dermatology

Alternative image

Medical devices

Alternative image

Biomaterials